LOSS PER COMMON SHARE - Antidilutive (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Shares subject to unvested or deferred performance and restricted stock units | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Shares subject to (in shares) | 377,812 | 112,949 |
| Shares subject to stock options outstanding | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Shares subject to (in shares) | 35,975 | 44,374 |